Offer - Urjas Oil for just ₹ 1 X
Diligan 12.5 Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Nausea and Vomiting. Other than this, Diligan 12.5 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Diligan 12.5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Diligan 12.5 Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Diligan 12.5 Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Diligan 12.5 Tablet's effect during pregnancy is Safe and Moderate while nursing. It is important to know if Diligan 12.5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Diligan 12.5 Tablet related warnings section.
Individuals suffering from medical conditions like Glaucoma must refrain from the use of Diligan 12.5 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Diligan 12.5 Tablet contraindications section.
Besides this, Diligan 12.5 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Diligan 12.5 Tablet is considered not safe while driving, and is not addictive.
Diligan 12.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Diligan 12.5 Tablet safe for pregnant women?
Pregnant women can take Diligan safely.
Is the use of Diligan 12.5 Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Diligan. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Diligan 12.5 Tablet on the Kidneys?
Very few cases of side effects of Diligan on kidney have been reported.
What is the effect of Diligan 12.5 Tablet on the Liver?
Side effects of Diligan rarely affect the liver.
What is the effect of Diligan 12.5 Tablet on the Heart?
You can take Diligan without any fear of damage to the heart.
Diligan 12.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Diligan 12.5 Tablet unless your doctor advises you to do so -
Is this Diligan 12.5 Tablet habit forming or addictive?
No, there is no any evidence that Diligan 12.5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Diligan 12.5 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but take Diligan 12.5 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Diligan 12.5 Tablet is not used to treat mental disorders.
Interaction between Food and Diligan 12.5 Tablet
Taking Diligan 12.5 Tablet with food does not cause any problems.
Interaction between Alcohol and Diligan 12.5 Tablet
Consuming Diligan 12.5 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Antivert® (meclizine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 46-47